Along those lines, I'm excited to share that as of this summer, the third major PBM will also begin covering Dexcom G7 for anyone with diabetes in some of their key formularies. Having the 3 ...

I wore Dexcom’s over-the-counter blood glucose monitor for a month. Here’s how it compares to Lingo and what it’s like to use ...

Discover Dexcom's Q1 2025 earnings highlights, including 14% revenue growth, expanded type 2 diabetes coverage, and the upcoming launch of the 15-day ...

The tech-heavy Nasdaq led the rally among all major indices, finishing up by 1.51 percent ... our product portfolio with the launch of our Dexcom G7 15-Day system and continue to advocate for ...

Continuous glucose meters (CGMs) aren’t just widgets for the wellness crowd. For many, CGMs are real-time feedback machines for the body, offering glucose trendlines that help people rethink ...

Dexcom (Nadsaq:DXCM) shares rose after hours today on first-quarter results that came in mixed compared to the consensus ...

Medical device maker Dexcom beat first-quarter sales estimates helped by strong demand for its continuous glucose monitors (CGMs) used by patients with diabetes.

DexCom, Inc. DXCM reported first-quarter 2025 adjusted earnings per share (EPS) of 32 cents, which missed the Zacks Consensus Estimate of 33 cents by 3% ... to $1.04 billion year over year.